Abstract
The aim of the study was to assess the plasma fibrinogen levels in type 2 diabetes mellitus patients and to compare with that of healthy controls. To correlate plasma fibrinogen levels with blood pressure (BP), BMI (Body Mass Index) and HbA1c (Glycated hemoglobin) among diabetics and healthy controls. Blood samples were collected for Plasma fibrinogen levels and HbA1c from 30 diagnosed type 2 diabetes mellitus patients. Their BP and BMI were recorded. 30 age and sex matched healthy subjects were included as a control group. There was a rise in plasma fibrinogen levels in diabetics with BMI < 25 kg/m2 as compared to controls of the same BMI group (P = 0.097). Also, there was a trend of raised plasma fibrinogen levels among male diabetics as compared to male control subjects (P = 0.079). However, there appears no such difference among female individuals. However, there was no significant correlation between fibrinogen levels, blood pressure and HbA1c both among controls and diabetic cases (P >0.05). Though there was a slight trend of increasing levels of plasma fibrinogen among diabetics as compared to controls. However, a significant positive correlation between BMI, male gender and increasing age with plasma fibrinogen was found.
Similar content being viewed by others
References
Hadi HA, Suwaidi JA. Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag. 2007;3:853–76.
Guerci B, Kearney-Schwartz A. Endothelial dysfunction and type 2 diabetes. Part 1: physiology and methods for exploring the endothelial function. Diabetes Metab. 2001;27:425–34.
Avogaro A, Kreutzenberg SV. Endothelial dysfunction: causes and consequences in patients with diabetes mellitus. Diabetes Res Clin Pract. 2008;15:S94–101.
Le DS, Miles R. The association of plasma fibrinogen concentration with diabetic microvascular complications in young adults with early-onset of type 2 diabetes. Haematolgia. 2008;82:317–23.
Panwar RB, Gupta R. Atherothrombotic risk factors & premature coronary heart disease in India: a case–control study. Indian J Med Res. 2011;134:26–32.
Chugh SN, Dabla S. Evaluation of endothelial function and effect of glycemic control (excellent vs. poor/fair control) on endothelial function in uncontrolled type 2 diabetes mellitus. J Assoc Physicians India. 2010;58:478–80.
Aboul Ella NA, Sheehab D. Prevalence of metabolic syndrome and insulin resistance among Egyptian adolescents 10 to 18 years of age. J Clin Lipidol. 2010;4:185–95.
Pieters M, Van Zyl DG. Glycation of fibrinogen in uncontrolled diabetic patients and the effects of glycaemic control on fibrinogen glycation. Thromb Res. 2007;120:439–46.
Langouche L, Meersseman W. Effect of insulin therapy on coagulation and fibrinolysis in medical intensive care patients. Crit Care Med. 2008;36:1475–80.
Conflict of interest
We declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Desai, K.N.P., Roopakala, M.S., Silvia, C.R.W.D. et al. Evaluation of plasma fibrinogen levels in type 2 diabetes mellitus. Int J Diabetes Dev Ctries 32, 209–213 (2012). https://doi.org/10.1007/s13410-012-0093-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13410-012-0093-z